🔗 Permalink

Inventor profile of:

Andrew C. Good

City:

Wallingford, Connecticut

Country:

United States

Published Applications:

Last publication date:

2025-02-27

Top Assignees for applications by Andrew C. Good

The entities that hold a legal rights for patent applications filed by inventor Good Andrew C.:

BRISTOL-MYERS SQUIBB COMPANY 22 Princeton, NJ United States
Bial—R&D Investments, S.A. 7 Coronado, Portugal
Lysosomal Therapeutics Inc. 5 Cambridge, MA United States
BIAL—BioTech Investments, Inc. 2 Coronado, Portugal
NOLIVA THERAPEUTICS LLC 2 West Newton, MA United States
Bristol-Meyers Squibb Company 1 Princeton, NJ United States
Bial—R & D Investments, S.A. 1 Coronado, Portugal

Recent patent applications by Good Andrew C.

Andrew C. Good from Wallingford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-27

US20250066364A1

Chemistry; metallurgy

SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#2 | 2023-03-30

US20230098494A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators

#3 | 2022-06-02

US20220169652A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders

#4 | 2021-10-07

US20210309661A1

Chemistry; metallurgy

Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders

#5 | 2021-06-17

US20210177853A1

Human necessities

Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders

#6 | 2021-06-10

US20210169886A1

Human necessities

Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders

#7 | 2020-12-10

US20200385390A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders

#8 | 2020-01-30

US20200030331A1

Human necessities

Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders

#9 | 2019-12-26

US20190389856A1

Chemistry; metallurgy

Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders

#10 | 2019-10-31

US20190330213A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders

#11 | 2019-10-17

US20190315751A1

Chemistry; metallurgy

Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders

#12 | 2019-07-18

US20190216813A1

Human necessities

Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders

#13 | 2019-04-25

US20190119283A1

Chemistry; metallurgy

Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders

#14 | 2019-04-18

US20190112316A1

Chemistry; metallurgy

THIAZOLO[3,2-A] PYRIMIDINONE AND OTHER HETEROBICYCLIC PYRIMIDINONE COMPOUNDS FOR USE IN MEDICAL THERAPY

#15 | 2019-03-28

US20190092789A1

Chemistry; metallurgy

HETEROBICYCLIC PYRIMIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#16 | 2018-07-05

US20180185368A1

Human necessities

SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#17 | 2017-11-23

US20170334916A1

Chemistry; metallurgy

Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders

#18 | 2017-11-23

US20170333435A1

Human necessities

SUBSTITUTED IMIDAZO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

#19 | 2017-02-09

US20170037085A1

Chemistry; metallurgy

Peptidomimetic compounds

#20 | 2016-10-27

US20160311778A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#21 | 2015-12-10

US20150353606A1

Chemistry; metallurgy

Peptidomimetic compounds

#22 | 2015-01-08

US20150011754A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#23 | 2014-07-24

US20140205564A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#24 | 2014-01-16

US20140017195A1

Human necessities

Hepatitis C virus inhibitors

#25 | 2013-10-24

US20130280211A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#26 | 2013-02-07

US20130034520A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#27 | 2013-01-03

US20130004457A1

Human necessities

Hepatitis C virus inhibitors

#28 | 2012-12-27

US20120328570A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#29 | 2010-09-16

US20100233120A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#30 | 2010-08-26

US20100215616A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#31 | 2010-03-18

US20100068176A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#32 | 2009-09-17

US20090233925A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#33 | 2009-08-13

US20090202483A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#34 | 2009-08-13

US20090202478A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#35 | 2009-03-12

US20090068140A1

Human necessities

Hepatitis C virus inhibitors

#36 | 2008-12-18

US20080311075A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#37 | 2008-12-04

US20080299075A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#38 | 2008-08-14

US20080194535A1

Chemistry; metallurgy

Diaminopropane derived macrocycles as inhibitors of β amyloid production

#39 | 2008-06-26

US20080153868A1

Chemistry; metallurgy

Substituted tetrahydroisoquinolines as β-secretase inhibitors

#40 | 2008-02-28

US20080050336A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#41 | 2008-02-21

US20080044380A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#42 | 2008-02-21

US20080044379A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#43 | 2007-02-15

US20070037868A1

Chemistry; metallurgy

Macrocyclic diaminopropanes as beta-secretase inhibitors

#44 | 2007-01-18

US20070015754A1

Chemistry; metallurgy

Acyl guanidines as beta-secretase inhibitors

InventorID:

10486 ⎘